Home/Stocks/Krishna Institute of Medical Sciences Ltd.
NSE: KIMS · Pharma & Health

Krishna Institute of Medical Sciences Ltd.

768.45 1.63%
Open
756.70
High
785.85
Low
756.70
Prev close
756.10
Volume
8,89,873

Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →

What Krishna Institute of Medical Sciences does

Krishna Institute of Medical Sciences operates a chain of multi-specialty hospitals concentrated in Andhra Pradesh and Telangana, with its flagship in Secunderabad, offering tertiary and quaternary care across cardiology, oncology, neurology and transplants. Known for a cost-efficient, doctor-partnership operating model; expanding into new clusters including Maharashtra (Nagpur), Bengaluru and Kerala through greenfield and acquisition routes.

The largest corporate hospital network in the Telangana/Andhra Pradesh region by bed count.

Listing and classification

NSE symbol
KIMS
ISIN
INE967H01025
Sector
Pharma & Health
Sub-sector
Healthcare Services
Market-cap tier
Small Cap
Market-cap rank
#1194

Krishna Institute of Medical Sciences Ltd. is a constituent of NIFTY 500, NIFTY SMALLCAP 250. See where it sits on the market heatmap →

Financial ratios, as filed

Consolidated annual figures taken from Krishna Institute of Medical Sciences Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).

Per-share figures are not restated. Shares outstanding changed from 8.00 crore to 40.00 crore in FY25, consistent with a bonus issue or stock split. Each year's EPS and book value below are as that year was filed, on that year's share count — so the per-share line falls across FY25 even where profit did not. Compare the absolute figures (EBITDA, free cash flow, total debt) and the margins across that boundary, not the per-share ones.

Krishna Institute of Medical Sciences Ltd. — key consolidated ratios by financial year
MetricFY26FY25FY24
EPS (basic, ₹)6.039.6138.75
Book value / share (₹)63.9660.47261.56
Return on equity9.4%15.9%14.8%
Return on capital employed8.0%12.4%14.5%
Operating margin13.3%20.0%19.8%
Net margin6.2%13.7%13.4%
EBITDA₹802 Cr₹783 Cr₹640 Cr
Free cash flow₹-917 Cr₹-427 Cr₹-126 Cr
Total debt₹3,244 Cr₹2,557 Cr₹1,355 Cr
Debt to equity1.271.060.65
Interest coverage2.66.710.5
Current ratio0.760.831.31
Shares outstanding40,00,00,00040,00,00,0008,00,27,800

Open the full income statement, balance sheet and cash flow for KIMS

Shareholding pattern

As disclosed for the quarter ended 30 Jun 2026.

Promoter & group
32.50%
FII / FPI
14.74%
DII
34.43%
Public
67.50%

Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →

Peers in Healthcare Services

Companies Alphave classifies in the same sub-sector, closest by market capitalisation.

What this page will not tell you

Whether to buy it
Alphave is NISM-certified, not a SEBI-registered research analyst. There is no target price, rating or recommendation anywhere on this page, and there will not be one.
A forecast of next quarter
Every figure above is filed history. Alphave publishes what companies reported, not what they might report.
Intraday precision
The quote on this page is cached and stamped with its as-of time. For live prices that update while you watch, use the chart.